The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis
- 1 February 1992
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 44 (2) , 147-154
- https://doi.org/10.1016/0090-8258(92)90030-m
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tumor markers in gynecologic oncologyGynecologic Oncology, 1990
- CA 15-3 as a tumor marker in gynecological malignanciesGynecologic Oncology, 1988
- An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaGynecologic Oncology, 1988
- Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancerGynecologic Oncology, 1988
- Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinomaGynecologic Oncology, 1987
- A radioimmunoassay for the detection of a human tumor‐associated glycoprotein (tag‐72) using monoclonal antibody B72.3International Journal of Cancer, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Immunochemical demonstration of an ovarian cancer‐associated urinary peptideInternational Journal of Cancer, 1982
- Carcinoembryonic Antigen (CEA) and Carbohydrate Determinant 19–9 (CA 19–9) Localization in 121 Primary and Metastatic Ovarian TumorsInternational Journal of Gynecological Pathology, 1982